MedTrace Logo

Efficacy and Safety of Tenoten in the Treatment of Children With Anxiety Disorders

NCT05605938 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2022-11-04

No results posted yet for this study

Summary

Purpose of the study:

• evaluate the efficacy and safety of Tenoten for children in children with anxiety disorders.

Conditions

  • Anxiety Disorder of Childhood

Interventions

DRUG

Tenoten for children

Oral administration

DRUG

Placebo

Oral administration

Sponsors & Collaborators

  • Materia Medica Holding

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-28
Primary Completion
2011-10-28
Completion
2011-10-28

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05605938 on ClinicalTrials.gov